Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats

Cellular Physiology and Biochemistry

Volumn 27, Issue 3-4, 2011, Pages 273-280

  Periasamy, Srinivasan ^a   Mo, Fan E ^a   Chen, Shin Yi ^a   Chang, Chih Ching ^a   Liu, Ming Yie ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Blood pressure; Electrocardiography; Heart rate; Isoproterenol; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Myocardial infarction; Sesamol

Indexed keywords

CARDIOVASCULAR AGENT; CREATINE KINASE MB; GELATINASE A; GELATINASE B; ISOPRENALINE; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE INHIBITOR; SESAMOL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; HEART MUSCLE; HEART PROTECTION; HEART RATE; HISTOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; P WAVE; PR INTERVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QRS COMPLEX; RAT; SYSTOLIC BLOOD PRESSURE; T WAVE;

RATTUS;

EID: 79953780611     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327953     Document Type: Article

References (29)

1. Spodick DH: Decreased recognition of the postmyocardial infarction (Dressler) syndrome in the post infarct setting: does it masquerade as "idiopathic pericarditis" following silent infarcts? Chest 2004;126:1410-1411.
2. Davis TM, Fortun P, Mulder J, Davis WA, Bruce DG: Silent myocardial infarction and its prognosis in a community-based cohort of type 2 diabetic patients: the Fremantle Diabetes Study. Diabetologia 2004;47:395-399. (Pubitemid 38491234)
3. Korkmaz S, Radovits T, Barnucz E, Hirschberg K, Neugebauer P, Loganathan S, Veres G, Páli S, Seidel B, Zöllner S, Karck M, Szabó G: Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury. Circulation 2009;120:677-686.
4. Rona G: Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306.
5. Chagoya de Sánchez V, Hernández-Muñoz R, López-Barrera F, Yañez L, Vidrio S, Suárez J, Cota-Garza MD, Aranda-Fraustro A, Cruz D: Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can J Physiol Pharmacol 1997;75:1300-1311. (Pubitemid 28130369)
6. Buttros JB, Bergamaschi CT, Ribeiro DA, Fracalossi AC, Campos RR: Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology 2009;84:29-37.
7. Peterson JT, Li H, Dillon L, Bryant JW: Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 2000;46:307-315. (Pubitemid 30204603)
8. Hsu DZ, Li YH, Chien SP, Liu MY: Effects of sesame oil on oxidative stress and hepatic injury after cecal ligation and puncture in rats. Shock 2004;21:466-469.
9. Fukuda Y: Food chemical studies on the antioxidants in sesame seed. Nippon Shokuhin Kogyo Gakkaishi 1990;37:484-492.
10. Chandrasekaran VR, Hsu DZ, Liu MY: The protective effect of sesamol against mitochondrial oxidative stress and hepatic injury in acetaminophen-overdosed rats. Shock 2009;32:89-93.
11. Hsu DZ, Wan CH, Hsu HF, Lin YM, Liu MY: The prophylactic protective effect of sesamol against ferric-nitrilotriacetate-induced acute renal injury in mice. Food Chem Toxicol 2008;46:2736-2741.
12. Hsu DZ, Chu PY, Li YH, Liu MY: Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock 2008;30:456-462.
13. Hsu DZ, Chien SP, Chen KT, Liu MY: The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice. Shock 2007;28:596-601.
14. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA: Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 1996;67:251-259. (Pubitemid 26185603)
15. Zeydanli EN, Turan B: Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Can J Physiol Pharmacol 2009;87:1063-1073.
16. Feng W, Li W: The study of ISO induced heart failure rat model. Exp Mol Pathol 2010;88:299-304.
17. Menon B, Singh M, Singh K: Matrix metalloproteinases mediate beta -adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes. Am J Physiol Cell Physiol 2005;289:C168-C176. (Pubitemid 40880837)
18. Miura S, Ohno I, Suzuki J, Suzuki K, Okada S, Okuyama A, Nawata J, Ikeda J, Shirato K: Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by beta-adrenergic stimulation in rats. J Cardiovasc Pharmacol 2003;42:174-181. (Pubitemid 36899668)
19. Heather LC, Catchpole AF, Stuckey DJ, Cole MA, Carr CA, Clarke K: Isoproterenol induces in vivo functional and metabolic abnormalities; similar to those found in the infarcted rat heart. J Physiol Pharmacol 2009;3:31-39.
20. Králová E, Mokrán T, Murín J, Stankovicová T: Electrocardiography in two models of isoproterenol- induced left ventricular remodeling. Physiol Res 2008;57:S83-89.
21. Hurst JW: Current Perspective: Naming of the waves in the ECG, with a brief account of their genesis. Circulation 1998;98:1937-1942.
22. Albayrak F, Bayir Y, Halici Z, Kabalar E, Bayram E, Ozturk C, Suleyman H, Keles MS, Kurt M, Bakan E: Preventive effect of amiodarone during acute period n isoproterenol-induced myocardial injury in wistar rats. Cardiovasc Toxicol 2009;9:161-168.
23. Tanwar V, Sachdeva J, Golechha M, Kumari S, Arya DS: Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of hsp27 along with strengthening antioxidant defense system. J Cardiovasc Pharmacol 2010;55:377-384.
24. Yuan J, Wu J, Hang ZG, Zhong XK, Zhou LW, Yu B: Role of peroxisome proliferator-activated receptor α activation in acute myocardial damage induced by isoproterenol in rats. Chin Med J (Engl) 2008;121:1569-1573.
25. Acikel M, Buyukokuroglu ME, Erdogan F, Aksoy H, Bozkurt E, Senocak H: Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int J Cardiol 2005;98:389-394. (Pubitemid 40247926)
26. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001;89:201-210.
27. Peterson JT, Li H, Dillon L, Bryant JW: Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 2000;46:307-315. (Pubitemid 30204603)
28. Spinale FG, Coker ML, Bond BR, Zellner JL: Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000;46:225-238. (Pubitemid 30204594)
29. Vennila L, Pugalendi KV: Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep 2010;15:36-42.